Author:
Gonçalves Daniela,Alves Gilberto,Fortuna Ana,Soares-da-Silva Patrício,Falcão Amílcar
Funder
Fundação para a Ciência e a Tecnologia
BIAL – Portela & Cª S.A.
Reference31 articles.
1. Pharmacokinetics, pharmacodynamics and tolerability of opicapone, a novel catechol-O-methyltransferase inhibitor, in healthy subjects: prediction of slow enzyme-inhibitor complex dissociation of a short-living and very long-acting inhibitor;Almeida;Clin. Pharmacokinet.,2013
2. Species differences in pharmacokinetic and pharmacodynamic properties of nebicapone;Bonifácio;Biochem. Pharmacol.,2009
3. Potential drug toxicity of nitrocatechol COMT inhibitors in HepaRG;Bonifácio;Toxicol. Lett.,2015
4. Pharmacological profile of opicapone, a third-generation nitrocatechol catechol-O-methyl transferase inhibitor, in the rat;Bonifácio;Br. J. Pharmacol.,2015
5. The rise and fall of tolcapone;Colosimo;J. Neurol.,1999
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献